Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-053376
Filing Date
2021-08-25
Accepted
2021-08-25 19:32:24
Documents
2
Period of Report
2021-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5624
2 POA DOCUMENT poa.txt EX-24.4_1005771 3126
  Complete submission text file 0001209191-21-053376.txt   10091
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 ACORN LANE LOS ALTOS CA 94022
Business Address
CANO FRANCIS (Reporting) CIK: 0001286710 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 211208339